Paroxysmal sympathetic hyperactivity (PSH) is widely described as occurring during intensive care, but in a number of patients it may last longer into the rehabilitation phase. Furthermore, drug therapy has been based on isolated observations. In this study, our aims are to describe a group of 26 pediatric rehabilitation patients with PSH and to quantify the effect of several drugs used to suppress PSH episodes.
Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation : Clinical Factors and Acute Pharmacological Management / M. Pozzi, V. Conti, F. Locatelli, S. Galbiati, S. Radice, G. Citerio, E. Clementi, S. Strazzer. - In: JOURNAL OF HEAD TRAUMA REHABILITATION. - ISSN 0885-9701. - 30:5(2015 Oct 13), pp. 357-363. [10.1097/HTR.0000000000000084]
Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation : Clinical Factors and Acute Pharmacological Management
F. Locatelli;S. Radice;E. ClementiPenultimo
;
2015
Abstract
Paroxysmal sympathetic hyperactivity (PSH) is widely described as occurring during intensive care, but in a number of patients it may last longer into the rehabilitation phase. Furthermore, drug therapy has been based on isolated observations. In this study, our aims are to describe a group of 26 pediatric rehabilitation patients with PSH and to quantify the effect of several drugs used to suppress PSH episodes.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
